Fundraising FoxO11 biomedical GmbH
also invests · investor profileMunich, DE · 1 known investors
Find your way into O11 biomedical GmbH
Sign up to see every warm intro you have to O11 biomedical GmbH
- Paths you didn't know you had: your email and LinkedIn already hold routes to the O11 biomedical GmbH team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Dimericon Therapeutics is a biotech company developing crosslinked helix dimers ("Dimericons") as therapeutics and as templates for small-molecule development, targeting hard-to-drug intracellular protein-protein interactions. Its lead program focuses on hematological malignancies, with a seed round supporting preclinical work toward an IND-ready clinical candidate.
Founders & leadership
Board
CL
DM
Investors · 1
Related companies · 2
PreqinPreqin provides a data and intelligence platform for investment teams, M&A professionals, and corporate development teams to source, evaluate, and value private company investments through integrated asset, fund, and performance data.
TipRanksFinancial analysis and stock research platform.
Companies working in the same space as O11 biomedical GmbH.
Frequently asked questions
- What does O11 biomedical GmbH do?
- Dimericon Therapeutics is a biotech company developing crosslinked helix dimers ("Dimericons") as therapeutics and as templates for small-molecule development, targeting hard-to-drug intracellular protein-protein interactions. Its lead program focuses on hematological malignancies, with a seed round supporting preclinical work toward an IND-ready clinical candidate.
- Who are O11 biomedical GmbH's investors?
- O11 biomedical GmbH's investors include CARMA FUND.
- Where is O11 biomedical GmbH headquartered?
- O11 biomedical GmbH is headquartered in Munich, DE.